News

12/19/24

KdT Ventures Nabs Over 100 Million for Early-Stage Investments

12/19/24

NGM Bio and KdT Ventures Enter into Worldwide License Agreement for NGM313, a Phase 2-ready FGFR1c/β-Klotho Agonist Drug Candidate

1/16/24

ZymoChem Closes $21M Series A Round Led by Breakout Ventures with Investments from lululemon and Toyota Ventures

12/14/23

Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb

11/9/23

Terray Therapeutics Announces Investment from NVIDIA to Enable Generative AI Design for Drug Discovery

11/8/23

ZymoChem Awarded $4 Million to Manufacture Bio-Based Polymers

6/22/23

Bayer-partnered Azitra hopes to apply $7.5M IPO proceeds to near-clinical dermatology pipeline

10/12/22

Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google’s Calico

10/12/22

‘Pluck those diamonds’: Bayer’s Vividion eyes up to nine oncology targets from Duke spinout

10/6/22

Ginkgo Bioworks acquires circular RNA biotech Circularis

12/19/24

KdT Ventures Nabs Over 100 Million for Early-Stage Investments

12/19/24

NGM Bio and KdT Ventures Enter into Worldwide License Agreement for NGM313, a Phase 2-ready FGFR1c/β-Klotho Agonist Drug Candidate

1/16/24

ZymoChem Closes $21M Series A Round Led by Breakout Ventures with Investments from lululemon and Toyota Ventures

12/14/23

Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb

11/9/23

Terray Therapeutics Announces Investment from NVIDIA to Enable Generative AI Design for Drug Discovery

11/8/23

ZymoChem Awarded $4 Million to Manufacture Bio-Based Polymers

6/22/23

Bayer-partnered Azitra hopes to apply $7.5M IPO proceeds to near-clinical dermatology pipeline

10/12/22

Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google’s Calico

10/12/22

‘Pluck those diamonds’: Bayer’s Vividion eyes up to nine oncology targets from Duke spinout

10/6/22

Ginkgo Bioworks acquires circular RNA biotech Circularis

Prev
Next